Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Videoconferencing | 3 | 2019 | 15 | 0.700 |
Why?
|
| Urban Health Services | 2 | 2011 | 45 | 0.670 |
Why?
|
| Urban Health | 2 | 2013 | 56 | 0.550 |
Why?
|
| Primary Health Care | 3 | 2019 | 351 | 0.530 |
Why?
|
| Community-Based Participatory Research | 2 | 2013 | 36 | 0.520 |
Why?
|
| Data Collection | 2 | 2013 | 375 | 0.470 |
Why?
|
| Residence Characteristics | 2 | 2013 | 200 | 0.460 |
Why?
|
| Cities | 1 | 2013 | 43 | 0.440 |
Why?
|
| Education, Medical, Continuing | 2 | 2019 | 105 | 0.440 |
Why?
|
| Family Practice | 1 | 2013 | 82 | 0.410 |
Why?
|
| Community Health Workers | 1 | 2012 | 33 | 0.400 |
Why?
|
| Education | 1 | 2011 | 58 | 0.390 |
Why?
|
| HIV Infections | 5 | 2006 | 835 | 0.390 |
Why?
|
| Urban Population | 1 | 2012 | 224 | 0.370 |
Why?
|
| Students | 1 | 2012 | 169 | 0.360 |
Why?
|
| Physicians, Primary Care | 1 | 2011 | 105 | 0.350 |
Why?
|
| AIDS Vaccines | 2 | 2006 | 10 | 0.340 |
Why?
|
| Internal Medicine | 1 | 2013 | 355 | 0.330 |
Why?
|
| Telemedicine | 1 | 2011 | 185 | 0.320 |
Why?
|
| Hypertension | 1 | 2011 | 741 | 0.260 |
Why?
|
| Chicago | 6 | 2019 | 1423 | 0.250 |
Why?
|
| Health Status | 1 | 2007 | 370 | 0.240 |
Why?
|
| Patient Education as Topic | 1 | 2007 | 359 | 0.220 |
Why?
|
| Models, Educational | 2 | 2013 | 48 | 0.210 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 1 | 2001 | 7 | 0.190 |
Why?
|
| Asthma | 2 | 2015 | 976 | 0.180 |
Why?
|
| Hepatitis B Vaccines | 1 | 1999 | 16 | 0.170 |
Why?
|
| Mycobacterium | 1 | 1999 | 18 | 0.170 |
Why?
|
| Bacterial Vaccines | 1 | 1999 | 42 | 0.170 |
Why?
|
| Mentoring | 1 | 2019 | 32 | 0.160 |
Why?
|
| Geriatrics | 1 | 2019 | 66 | 0.150 |
Why?
|
| Electronic Prescribing | 1 | 2016 | 11 | 0.140 |
Why?
|
| Population Health | 1 | 2016 | 33 | 0.140 |
Why?
|
| Infant | 5 | 2015 | 3147 | 0.140 |
Why?
|
| Enterovirus D, Human | 1 | 2015 | 4 | 0.130 |
Why?
|
| Enterovirus Infections | 1 | 2015 | 41 | 0.130 |
Why?
|
| Community Health Centers | 1 | 2016 | 115 | 0.130 |
Why?
|
| HIV-1 | 2 | 2006 | 166 | 0.120 |
Why?
|
| Health Promotion | 1 | 2016 | 163 | 0.120 |
Why?
|
| Respiratory Tract Infections | 1 | 2015 | 106 | 0.120 |
Why?
|
| Disease Outbreaks | 1 | 2015 | 154 | 0.120 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 531 | 0.120 |
Why?
|
| Censuses | 1 | 2013 | 7 | 0.110 |
Why?
|
| Patient Dropouts | 1 | 2013 | 30 | 0.110 |
Why?
|
| Humans | 15 | 2019 | 89073 | 0.110 |
Why?
|
| Emergencies | 1 | 2013 | 121 | 0.110 |
Why?
|
| Infant, Newborn | 3 | 2015 | 2476 | 0.110 |
Why?
|
| Hospitals, Pediatric | 1 | 2013 | 115 | 0.110 |
Why?
|
| Child | 6 | 2015 | 7149 | 0.100 |
Why?
|
| Program Development | 1 | 2013 | 123 | 0.100 |
Why?
|
| Public Health | 1 | 2013 | 138 | 0.100 |
Why?
|
| Self-Assessment | 1 | 2011 | 47 | 0.100 |
Why?
|
| Interviews as Topic | 1 | 2013 | 334 | 0.100 |
Why?
|
| Program Evaluation | 1 | 2013 | 306 | 0.100 |
Why?
|
| Health Care Coalitions | 1 | 2011 | 9 | 0.090 |
Why?
|
| Surveys and Questionnaires | 3 | 2019 | 2612 | 0.090 |
Why?
|
| Female | 9 | 2019 | 46014 | 0.090 |
Why?
|
| Child, Preschool | 4 | 2015 | 3717 | 0.090 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2013 | 257 | 0.090 |
Why?
|
| Community-Institutional Relations | 1 | 2011 | 29 | 0.090 |
Why?
|
| Educational Measurement | 1 | 2013 | 231 | 0.090 |
Why?
|
| Patient Preference | 1 | 2011 | 108 | 0.090 |
Why?
|
| Teaching | 1 | 2011 | 147 | 0.090 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2001 | 67 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2013 | 865 | 0.090 |
Why?
|
| Male | 8 | 2019 | 42254 | 0.090 |
Why?
|
| Lymphocyte Activation | 2 | 2005 | 751 | 0.090 |
Why?
|
| Patient Participation | 1 | 2011 | 224 | 0.080 |
Why?
|
| Disease Management | 1 | 2011 | 329 | 0.080 |
Why?
|
| HIV Antibodies | 2 | 2006 | 26 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2013 | 521 | 0.080 |
Why?
|
| Curriculum | 1 | 2013 | 567 | 0.080 |
Why?
|
| Case Management | 1 | 2007 | 25 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 2752 | 0.070 |
Why?
|
| Health Services | 1 | 2007 | 57 | 0.070 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2006 | 46 | 0.070 |
Why?
|
| Immunoglobulin A, Secretory | 1 | 2005 | 18 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2011 | 780 | 0.070 |
Why?
|
| Vaccines, Synthetic | 1 | 2005 | 55 | 0.060 |
Why?
|
| Mucous Membrane | 1 | 2005 | 83 | 0.060 |
Why?
|
| Adolescent | 4 | 2015 | 9237 | 0.060 |
Why?
|
| Adult | 3 | 2015 | 26508 | 0.060 |
Why?
|
| Saliva | 1 | 2005 | 123 | 0.060 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2005 | 319 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2007 | 461 | 0.060 |
Why?
|
| Medicaid | 1 | 2007 | 229 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2011 | 4273 | 0.050 |
Why?
|
| Measles virus | 1 | 2001 | 14 | 0.050 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2001 | 73 | 0.050 |
Why?
|
| Viral Load | 1 | 2001 | 145 | 0.050 |
Why?
|
| Double-Blind Method | 2 | 2006 | 1715 | 0.040 |
Why?
|
| Dapsone | 1 | 1999 | 10 | 0.040 |
Why?
|
| Skin Tests | 1 | 1999 | 44 | 0.040 |
Why?
|
| Hepatitis B Antibodies | 1 | 1999 | 15 | 0.040 |
Why?
|
| Administration, Cutaneous | 1 | 1999 | 60 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2001 | 309 | 0.040 |
Why?
|
| Immunization | 1 | 1999 | 160 | 0.040 |
Why?
|
| Anti-Infective Agents | 1 | 1999 | 91 | 0.040 |
Why?
|
| Antibodies, Bacterial | 1 | 1999 | 99 | 0.040 |
Why?
|
| Vaccination | 1 | 2001 | 273 | 0.040 |
Why?
|
| Self Efficacy | 1 | 2019 | 54 | 0.040 |
Why?
|
| Medical Informatics | 1 | 2016 | 49 | 0.030 |
Why?
|
| Missouri | 1 | 2015 | 19 | 0.030 |
Why?
|
| Colorado | 1 | 2015 | 37 | 0.030 |
Why?
|
| Respiratory Sounds | 1 | 2015 | 34 | 0.030 |
Why?
|
| Cough | 1 | 2015 | 55 | 0.030 |
Why?
|
| Dyspnea | 1 | 2015 | 75 | 0.030 |
Why?
|
| Fever | 1 | 2015 | 128 | 0.030 |
Why?
|
| Illinois | 1 | 2015 | 472 | 0.030 |
Why?
|
| Crowding | 1 | 2013 | 6 | 0.030 |
Why?
|
| Health Services Misuse | 1 | 2013 | 19 | 0.030 |
Why?
|
| Telephone | 1 | 2013 | 35 | 0.030 |
Why?
|
| Treatment Refusal | 1 | 2013 | 62 | 0.030 |
Why?
|
| Appointments and Schedules | 1 | 2013 | 54 | 0.030 |
Why?
|
| Hospitals, University | 1 | 2013 | 195 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 2015 | 352 | 0.030 |
Why?
|
| Critical Care | 1 | 2015 | 380 | 0.030 |
Why?
|
| Health Personnel | 1 | 2013 | 212 | 0.020 |
Why?
|
| Organizational Case Studies | 1 | 2011 | 28 | 0.020 |
Why?
|
| Models, Organizational | 1 | 2011 | 47 | 0.020 |
Why?
|
| Motivation | 1 | 2013 | 296 | 0.020 |
Why?
|
| Parents | 1 | 2013 | 285 | 0.020 |
Why?
|
| Universities | 1 | 2011 | 146 | 0.020 |
Why?
|
| Aged | 2 | 2019 | 19078 | 0.020 |
Why?
|
| Hospitalization | 1 | 2015 | 876 | 0.020 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2006 | 19 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 3657 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2006 | 178 | 0.020 |
Why?
|
| Breast Feeding | 1 | 2006 | 102 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 6777 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 5320 | 0.020 |
Why?
|
| Young Adult | 1 | 2015 | 6289 | 0.010 |
Why?
|
| United States | 1 | 2015 | 6957 | 0.010 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1999 | 18 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1999 | 315 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 25865 | 0.010 |
Why?
|